(IBDW) iShares Trust - iShares - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E4860 • Target Maturity
IBDW: Corporate, Bonds, Fixed, Income, Securities
The iShares iBonds Dec 2031 Term Corporate ETF (IBDW) is structured to track an index of U.S. dollar-denominated, taxable, investment-grade corporate bonds, specifically those maturing between January 1, 2031, and December 15, 2031. This ETF is part of a category known as target maturity funds, which are designed to provide investors with a predictable return profile as the bonds approach their maturity dates.
As a non-diversified fund, IBDW can concentrate its investments in a smaller number of securities, which may heighten risk but also has the potential to amplify returns. The fund commits at least 80% of its assets to the component instruments of its underlying index and allocates at least 90% to fixed income securities of the types included in the index, ensuring a focused investment strategy.
With an AUM of over $1.35 billion, IBDW benefits from economies of scale, which can contribute to lower expense ratios and tighter tracking error relative to its benchmark. This scale also enhances liquidity, making it easier for investors to buy and sell shares without significantly impacting the price. The fund’s focus on investment-grade corporate bonds means it emphasizes credit quality, reducing default risk compared to lower-rated debt. However, like all fixed income securities, it remains exposed to interest rate risk, which can cause price fluctuations in the portfolio.
Additional Sources for IBDW ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBDW ETF Overview
Market Cap in USD | 1,405m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2021-06-22 |
IBDW ETF Ratings
Growth 5y | 8.63% |
Fundamental | - |
Dividend | 75.6% |
Rel. Strength Industry | -2.09 |
Analysts | - |
Fair Price Momentum | 20.09 USD |
Fair Price DCF | - |
IBDW Dividends
Dividend Yield 12m | 4.59% |
Yield on Cost 5y | 4.35% |
Annual Growth 5y | 38.84% |
Payout Consistency | 100.0% |
IBDW Growth Ratios
Growth Correlation 3m | 70% |
Growth Correlation 12m | 74.5% |
Growth Correlation 5y | -8.9% |
CAGR 5y | -1.20% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | 1.49 |
Alpha | 1.17 |
Beta | 0.15 |
Volatility | 4.78% |
Current Volume | 209.7k |
Average Volume 20d | 236.5k |
As of March 14, 2025, the stock is trading at USD 20.60 with a total of 209,700 shares traded.
Over the past week, the price has changed by -0.39%, over one month by +1.14%, over three months by +1.25% and over the past year by +5.97%.
Neither. Based on ValueRay Analyses, iShares Trust - iShares is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 8.63 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBDW as of March 2025 is 20.09. This means that IBDW is currently overvalued and has a potential downside of -2.48%.
iShares Trust - iShares has no consensus analysts rating.
According to ValueRays Forecast Model, IBDW iShares Trust - iShares will be worth about 21.7 in March 2026. The stock is currently trading at 20.60. This means that the stock has a potential upside of +5.34%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 21.7 | 5.3% |